The PI3K–AKT–mTOR pathway is a key oncogenic signaling pathway, not only at the level of tumorigenesis but also in the development of therapy resistance of PCa and additional solid tumors23–28. This evidence concerns the gene AKT1 and posterior cortical atrophy.